Conclusions
This study shows that patients treated with PCI with n-DES have a lower risk of restenosis, ST, and death at 2 years compared with o-DES in a large real-world population. A significantly lower mortality was observed in both the DES groups compared with BMS in this study.
Large-scale randomized studies are needed to confirm these findings that can be useful for the management of patients with a high-risk profile for ST and restenosis.